
Driven by increasing healthcare spending worldwide amid a rapidly aging population and rising prevalence of chronic illness, growing disposable incomes, and rapid technological advancements, the pharmaceutical industry is poised for steady growth.
Given the industry’s tailwinds, investors could consider buying fundamentally solid pharma stocks Taro Pharmaceutical Industries Ltd. (TARO), AstraZeneca PLC (AZN), and Merck & Co., Inc. (MRK) for long-term growth. These stocks are rated A (Strong Buy) in our POWR Ratings system.